Expansion of Diagnostic Criteria Proposed for COPD
Expanded diagnostic criteria used to classify individuals with possible, probable, definite COPD.
MPR YIR COPD 2019
COPD Mortality Rates Decreasing in Many Countries
Number of COPD deaths increased by more than 10% in 11 of 24 countries studied.
New Cheek Swab Helps Rule Out Genetic Form of COPD
A new cheek swab, known as AlphaID (Grifols), has been made available for physicians to screen patients with chronic obstructive pulmonary disease (COPD) for alpha-1 antitrypsin deficiency (Alpha-1).
Certain Inhaled Corticosteroids Linked to Increased Pneumonia Risk in COPD
For patients with chronic obstructive pulmonary disease (COPD), inhaled corticosteroid (ICS) use was associated with an increased risk of pneumonia, according to the results of a recently published meta-analysis.
COPD Therapy Duaklir Pressair Now Available
Each actuation provides a metered dose of 12mg of the formulation which contains lactose monohydrate as the carrier, 400mcg of aclidinium bromide, and 12mcg of formoterol fumarate.
Occupational Use of Disinfectants May Up Risk for Developing COPD
Findings seen in longitudinal study of U.S. female nurses who cleaned surfaces, medical instruments
FDA Rejects NDA for Triple Combo COPD Therapy
The Food and Drug Administration has issued a complete response letter (CRL) to AstraZeneca regarding the Company’s New Drug Application (NDA) for PT010, an investigational triple combination therapy for chronic obstructive pulmonary disease (COPD). PT010 is a single inhaler, fixed-dose triple combination therapy of budesonide, an inhaled corticosteroid with glycopyrronium, a long-acting muscarinic antagonist (LAMA),…
Marijuana Use Examined Among Adults With Medical Conditions
Most surveyed adults reported smoking as their primary method of administration.
CRP-Guided Testing Cuts Antibiotic Use in COPD Exacerbations
Lower percentage of patients reported antibiotic use, received antibiotic prescriptions
Do Beta-Blockers Increase the Risk for COPD Exacerbations?
Cardioselective beta-blockers do not appear to increase the rate of exacerbations in patients with chronic obstructive pulmonary disease.
